A glance on the role of fibronectin in controlling cell response at biomaterial interface. by Parisi, Ludovica et al.
RA
b
L
S
a
b
c
a
A
R
R
A
K
F
B
T
R
B
1
f
t
t
o
t
p
s
h
t
t
i
a
g
F
(
h
1
(
0
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
94
08
 
| 
do
wn
lo
ad
ed
: 
16
.3
.2
02
0Japanese Dental Science Review 56 (2020) 50–55
Contents lists available at ScienceDirect
Japanese  Dental Science  Review
journa l homepage: www.e lsev ier .com/ locate / jdsr
eview  Article
 glance  on  the  role  of  ﬁbronectin  in  controlling  cell  response  at
iomaterial  interface
udovica  Parisi a,b,∗,  Andrea  Toffoli a, Benedetta  Ghezzia, Beatrice  Mozzonia,
imone  Lumetti a,  Guido  M.  Macalusoa,c
Centro Universitario di Odontoiatria, Dipartimento di Medicina e Chirurgia, Università di Parma, Via Gramsci 14, 43126 Parma, Italy
Labor für Orale Molekularbiologie, Klinik für Kieferorthopädie, Zahnmedizinische Klinik, Universität Bern, Freiburgstrasse 7, 3008 Bern, Switzerland
Istituto dei Materiali per l’Elettronica e l’Elettromagnetismo, Consiglio Nazionale delle Ricerche, Parco Area delle Scienze 17/A, 43124 Parma, Italy
 r  t  i  c  l e  i  n  f  o
rticle history:
eceived 5 December 2018
eceived in revised form 26 October 2019
ccepted 21 November 2019
eywords:
ibronectin
iomaterials
issue engineering
s  u  m  m  a  r  y
The  bioactivity  of biomaterials  is closely  related  to cell response  in  contact  with  them.  However,  shortly
after  their  insertion,  materials  are  soon  covered  with proteins  that  constitute  the  biological  ﬂuids,  and
which  render  the  direct surface  recognition  by  cells  almost  impossible.  The  control  of protein  adsorption
at  the  interface  is therefore  desirable.  Extracellular  matrix  proteins  are  of  particular  interest  in this  sense,
due to their  well-known  ability  to modulate  cell behavior.  Particularly,  ﬁbronectin  plays  a leading  role,
being present  in  both  healthy  and  injured  tissues  undergoing  healing  and  regeneration.  The  aim  of  the
present  work  is  to give  an  overview  on ﬁbronectin  and  on  its involvement  in the  control  of  cell behavior
providing  evidence  of its pivotal  role  in  the control  of  cell  adhesion,  spreading,  migration,  proliferationegenerative medicine
one regeneration
and  differentiation.  A  deep  insight  into  methods  to  enrich  biomaterials  surface  with  ﬁbronectin  will  be
then  discussed,  as  well  as new  cues on  the possibility  to design  tailored  platforms  able to speciﬁcally
retain ﬁbronectin  from  the  surrounding  extracellular  milieu.
© 2019  The  Authors.  Published  by Elsevier  Ltd on  behalf  of  The  Japanese  Association  for  Dental
Science.  This  is  an  open  access  article  under  the CC BY-NC-ND  license  (http://creativecommons.org/
licenses/by-nc-nd/. Introduction
Once a biomaterial is inserted in the host site, protein adsorption
rom biological ﬂuids, e.g. blood plasma, occurs rapidly, mediating
he interaction surface-cells. The composition of the adsorbed pro-
ein layer at the interface plays a vital role in determining the nature
f the tissue-material reciprocal fate, determining crucial charac-
eristics of cell response, including adhesion, spreading, migration,
roliferation and differentiation [1]. Particularly, some proteins can
timulate a constructive cells response, thus promoting wound
ealing and tissue regeneration, only when correctly presented. On
he other hand, when in different conformation or modiﬁed, pro-
eins may  trigger a host immune reaction leading to its removal or
solation. Regrettably, protein adsorption on biomaterials is mostly
 haphazard process and it is mainly driven by the chemical and
∗ Corresponding author. Present address: Labor für Orale Molekularbiolo-
ie,  Klinik für Kieferorthopädie, Zahnmedizinische Kliniken, Universität Bern,
reiburgstrasse 7, CH-3010 Bern, Switzerland.
E-mail addresses: ludovica.parisi@unipr.it, ludovica.parisi@zmk.unibe.ch
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ttps://doi.org/10.1016/j.jdsr.2019.11.002
882-7616/© 2019 The Authors. Published by Elsevier Ltd on behalf of The Japanese Associa
http://creativecommons.org/licenses/by-nc-nd/4.
/).4.0/).
physical characteristics of the material, as by protein availability
and reciprocal interactions, which may lead to the adsorption of
proteins which do not convey useful stimuli to cells because of
an impaired conformation [2,3]. Thus, controlling speciﬁc protein
adsorption at the interface of biomaterials may  represent a viable
approach in tissue engineering (TE), to design highly performant
scaffolds able to address cell activity in detail [4].
Fibronectin (FBN) is an extracellular matrix (ECM) component
that, through binding integrin receptors of the cell surface, acts
as a key player of the communication between the intra and the
extracellular environment, thus controlling cell behavior. Further-
more, in regenerative dentistry the role of FBN in promoting the
attachment of cells to root surface has been shown, as well as FBN
probable pivotal role in bone and periodontal regeneration is of
considerable interest [5]. Therefore, the modulation of integrin-
FBN interaction may  offer a promising approach to tailor tissue
regenerative responses, i.e. bone and periodontal regeneration
[6].The aim of the present concise narrative review is to focus
the research supporting this crucial role of FBN and the methods
developed to ameliorate scaffold bioactivity modulating func-
tion for Dental Science. This is an open access article under the CC BY-NC-ND license
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Table 1
The integrin family of adhesion receptors.
Cell integrin FBN and other ECM ligands Cell expressing integrin
3ß1 Fibronectin, collagen-I,
epiligrin, laminin, nidogen,
entactin
B-lymphocytes, kidney
glomerulus cells
4ß5 Fibronectin, VCAM-I Lymphocytes, monocytes,
eosinophils, NK-cells,
thymocytes
5ß1 Fibronectin Bone cells, memory T-cells,
monocytes, platelets,
ﬁbroblasts
8ß1 Fibronectin Not yet identiﬁed
Vß1 Fibronectin, vitronectin Not yet identiﬁed
Vß3 Fibronectin, ﬁbrinogem,
Von Willebrand’s factor,
vitronectin,
thrombospondin
Bone cells, endothelial
cells, B-cells, platelets,
monocytes
IIß3 Fibronectin ﬁbrinogen, Von
Willebrand’s factor,
PlateletsL. Parisi et al. / Japanese Dent
ional FBN availability at the cell-biomaterial interface in TE
pproaches.
. Fibronectin as a controller of cell behavior
The ECM is the non-cellular component of tissues and it basi-
ally provides physical scaffolding for cells, besides transmitting
iochemical and biomechanical stimuli required for tissue mor-
hogenesis and homeostasis. ECM main components are water,
roteoglycans and proteins. Proteoglycans ﬁll the major part of
he extracellular environment and are the responsible for ECM
orce-resistance properties [7]. While, proteins are involved in
rchestrating cell adhesion and migration. Among them, FBN is
n important cell-adhesive ECM protein, which is present also in
njured tissues undergoing regeneration. It exists into two main
orms: i) the soluble FBN, which is a major component of blood
lasma (300 g/ml) and it is synthetized by hepatocytes and ii) the
ess-soluble cellular FBN that is synthetized by different types of
broblasts to be then assembled into the ECMs [8]. FBN plays a key
ole in cell behaviors, such as adhesion, migration and differenti-
tion, as well as in morphogenesis and wound healing. As such,
BN and its mechanisms are clear candidates for the amelioration
f scaffold bioactivity.
.1. Fibronectin structure
FBN exists in human in more than 20 alternative splicing
soforms. Structurally, FBN is a dimeric high-molecular weight gly-
oprotein (∼440 kDa), composed by two nearly identical subunits
∼250 kDa) covalently bound by disulﬁde bonds near their C-term
ortion (Fig.1) [8]. Each of these subunits consists of three different
ypes of repeats: type I, II and III. Type I repeats are 12 modules of
0 amino acidic residues, structured as stacked ß-sheets, linked by
 disulphide bond, and that present a hydrophobic core made up
f aromatic conserved residues. Type II repeats (2 modules) are 60
esidues long, constituted by perpendicular antiparallel ß-sheets
inked together by 2 intra-chain disulphide bonds. Eventually, type
II repeats, are 90 residues long and between 15 and 17 modules.
hese repeats do not possess disulﬁde bonds and the antiparal-
el ß-sheets are linked together with ﬂexible loops and stabilized
hrough hydrogen bonding [9–11]. As such, type III repeats are the
ighest sensitive to possible FBN unfolding [12].
.2. Fibronectin–integrin recognition
FBN communication with cells occurs through integrin binding.
ntegrins are the main cell surface receptors that mediate cell-
atrix adhesion, some of which are ubiquitously expressed, while
thers are tissue-speciﬁc. Structurally, integrins are heterodimers
enerated by the coupling of 18-alpha () and 8-beta (ß) subunits,
hich speciﬁcally bind different ECM molecules. Each subunit con-
ists of a large extracellular domain with selectivity for ECM ligands,
 transmembrane domain and a short cytoplasmic tail. Because
ntegrins lack of intrinsic enzymatic activity, the cytoplasmic tail
f the ß subunit is structured to engage intracellular signaling
olecules after dimerization and to activate the integrin-mediated
ransduction pathway [13,14].
There are many different integrins recognizing FBN (Table 1) and
ach of them extremely depends on FBN structural conformation
nd on type III residues sensitiveness to unfolding. For example,
he classic receptor for FBN is known to be the 5ß1 integrin (FBN-
5ß1 Kd = 8 × 10−7 M)  [15]. The 5ß1 recognizes and binds FBN
hrough the interaction with an isolated tri-peptide sequence, the
rginine-glycine-aspartic acid (RGD), which is contained in the 10th
ype III repeat of FBN and that synergizes with a further sequence,
he proline-histidine-serine-arginine-asparagine (PHSRN), on thevitronectin
Vß6 Fibronectin Carconoma cells
adjacent 9th type III repeat of FBN [16]. In bulk conditions, the RGD
cell-binding domain and the recognition sequence PHSRN are sep-
arated from 32 Å. This distance results to be extremely important
for speciﬁc recognition between FBN and 5ß1 integrin. Indeed,
if FBN-10th III domain unfolds as an effect of a 10 pN external
force application, the RGD loop is pulled away from the PHSRN on
the FBN-9th III domain, resulting in a 23 Å removal, which greatly
diminishes the ability of 5ß1 integrin to recognize FBN, but which
enhances that of the Vß3 integrin isoform [12]. As a results, FBN
conformational changes may  dramatically drive integrin speciﬁcity
and pathophysiological cell and tissue responses, including the
reactions to grafted biomaterials.
2.3. Fibronectin and the control of cell behavior
Precisely, cell-FBN interaction occurs by synergic interplay of
proteins at three different level: i) FBN that offers docking points
for cells, ii) integrins that allow the recognition of the FBN and iii)
intracellular proteins that activate speciﬁc transduction pathways
to control cell response, including adhesion, spreading, migration,
proliferation and differentiation.
2.3.1. Cell adhesion and spreading
Cell adhesion refers both to the mechanisms by which neigh-
boring cells interact, attach or communicate each other by cell
junctions (cell–cell adhesion), as to the ability of cells to interact
with their surrounding ECM or with an artiﬁcial substrate through
focal contacts (cell–matrix adhesion) [17].
The sites of cell adhesion with the extracellular environment
are called focal adhesions. At this level, after integrin dimerization,
a network of 156 components and of more than 690 interactions
form the adhesome and lead in the end to cytoskeleton proteins
rearrangement. This wide spectrum of proteins may be divided in
three categories: i) integrin-binding proteins, ii) adaptors or scaf-
folding proteins and iii) enzymes [18]. Integrin-binding proteins are
directly recruited by the cytoplasmic tail of the integrin ß subunit.
Among them, the binding of talin have been established to have a
key role in integrin activation and it has been demonstrated that
competition for talin binding may  severely down-regulate integrin
transduction pathway activation. Thus, adaptors or scaffolding pro-
teins (e.g. vinculin, paxillin and -actinin), link integrin-associated
proteins with cytoskeleton components, while enzymes, which are
mainly tyrosine-associated kinases (e.g. focal adhesion kinase –
FAK, Rho family associated GTPases, Src), contribute to molecular
signal transmission [18].
52 L. Parisi et al. / Japanese Dental Science Review 56 (2020) 50–55
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GFig. 1. Fibronectin. Diagram representing the structure of ﬁbron
Cell spreading is directly connected to cell adhesion and it
s fundamental for subsequent proliferation, migration and dif-
erentiation, and a lack in cell adhesion/spreading may  result in
onsequent cell apoptosis [19,20].
As we stated above, FBN and many others ECM components, pos-
ess adhesive motifs with the ability to promote cell adhesion and
preading. Thus, these molecules may  be introduced on biomateri-
ls to modify cell response. For example, the coating of substrates
ith increasing amount of FBN, leads to an evident promotion of
ell adhesion and spreading in term of degree and speed [21–23].
o this purpose, in a recent research we have observed that ame-
iorating the hydrophilicity of titanium implant surfaces by heating
s a viable option to promote FBN adsorption from plasma serum,
hus improving the eventual adhesion of osteoblasts [24].
.3.2. Cell migration
Cell migration is a cellular activity crucial to scaffold coloniza-
ion, and directly depends on cell adhesion and spreading. It occurs
long the substrates through the formation of new focal adhesions
nd the release of the old ones. Physiologically, the human body has
ompositional gradients of soluble signals in tissues, which allow
he creation of a natural driving force to direct the migration of
ells (chemotaxis). Alternatively, substrate-attached factors (hap-
otaxis) or mechanical cues (durotaxis) may  govern cell migration
17].
More speciﬁcally, during cell migration processes, gradients
uide actin assembly to the cell’s leading edge, thus determin-
ng the direction of cell movement. At the migration front, the
ctivation of cell surface receptors, i.e. integrins, generates the acti-
ation of the Rho-family GTPases and of the phosphatidylinositol
iphosphate (PIP2) pathway, which in turn activate the WASp/Scar
roteins and eventually the Arp2/3 complex that guide the forma-
ion of new actin ﬁlaments branching from the preexisting ones.
his process leads to the pushing of cell membrane forward. Simul-
aneously, at the back side of the cells, myosin II interacts with old
ctin ﬁlaments to enhance local rigidity, preventing lateral ﬁlopo-
ia extension and allowing the retraction of the trailing end [25].
The abundance of FBN in the clot is closely related to ﬁbrob-
asts recruitment during wound healing. As such, FBN introduction
n biomaterials may  allow the creation of dynamic pathway for
ells to move along the scaffold [26]. Accordingly, Nuttelman et al.
bserved that NIH3T3 ﬁbroblasts migrated faster on poly(vinyl
lcohol) hydrogels modiﬁed with FBN, if compared to tissue culture
late and to control hydrogels [26]. Similarly, by means of aptamers
elected to recognize and bind FBN, we were so far able to improve
he migratory capacity of osteoblasts into a hyaluronic acid based
atrix [27].
.3.3. Cell proliferation
Cell proliferation consists in cell number growth as a conse-
uence of cell division. In adult organisms, cell proliferation is
enerally restricted to cell that replenish tissues. Cell division
ccurs as eventual stage of the cell cycle, which is broken up into
our moments. The G1 phase is the ﬁrst moment of a cell life and it
s mainly characterized by cell growth and development. G1 phase
s followed by the S phase, which consists in DNA replication. Thus,
2 phase, which is the gap before to cell division phase, ensures thesingle subunit. Repeats and binding domains (BD) are indicated.
proper replication of DNA and its packaging prior to cell division
(M phase) [28].
The progression of the cell cycle is positively regulated by a fam-
ily of protein kinases called cyclin-dependent kinases (Cdks), which
turn on speciﬁc genes promoting growth (cyclines) and off their
inhibitors at speciﬁc time. Particularly, the transition from G1 to S
phase, which is the most critical point in the cell cycle, is positively
regulated by Ckd2 and Ckd4, which induce cyclin E and cyclin D1
respectively, via the MAPK/ERK pathway [28]. A few studies have
correlated the induction of cyclin D1 by integrin signaling, high-
lighting that the integrin-dependent phosphorylation of FAK plays
a key role in the phosphorylation of ERK and in the induction of
cyclin D1.
Thus, the decoration of substrates with FBN may  be involved
in increasing cell proliferation [29,30]. Noteworthy, it has been
observed that FBN 5ß1 integrin activation mediates cell prolif-
eration through the activation of the MAPK/ERK associated to the
epithelial growth factor (EGF) receptor [29].
Still by using aptamers selected against FBN, we  have also been
able to promote the proliferative capacity of cells on chitosan [31];
and, we have further demonstrated that the molding of the cellular
behavior was  associated with the activation of the integrin pathway
due to a massive adsorption of FBN on chitosan surface [32].
2.3.4. Cell differentiation
Eventually, cell differentiation is the process that leads to a cell
to reach its specialized and mature phenotype, through the sig-
naling of a deﬁned combinations of transcription factors. Besides
growth factors, various kind of ECM-derived proteins have func-
tion in regulating cell differentiation [33]. In this sense, it has been
shown that active integrin signaling is essential for driving differ-
entiation: e.g. genetic removal of ß1 integrin subunits inhibits the
differentiation pathway of the epithelial cells. As such, tailoring the
quantity and activity of ﬁbronectin onto substrates could be used
to selectively guide cells fate. Fascinatingly, the capacity of FBN to
bind multiple integrins by slightly modulating its conformation,
represent a design challenge to control speciﬁc cell behavior dur-
ing their commitment. In a work by Martino et al. it was shown
the capacity of a structurally stabilized FBN III9*-10 domain to
promote osteogenic differentiation both in 2D and in 3D environ-
ment if compared to whole FBN or to the less speciﬁc FBN III9-10
or FBN III10 fragment. FBN III9*-10 presented a single mutation
that switched the Leucine1408 into a Proline on the III9 domain,
thus conferring to FBN enhanced afﬁnity for 5ß1 integrin [34].
This example demonstrate how engineered cellular adhesive inter-
action with the surrounding milieu can lead to cell commitment
control.
3. Fibronectin adsorption to biomaterials
As reported in the previous discussion, the adsorption of
proteins, particularly of FBN, is of the utmost relevance for
tissue-biomaterial interaction. However, body ﬂuids contain a het-
erogeneity of biomolecules and their adsorption on biomaterials
is a complex process. Blood, for instance, consists of more than
150 proteins further supplemented with lipids, carbohydrates and
other molecules that compete for their adsorption at the inter-
L. Parisi et al. / Japanese Dental Scie
Table  2
Exchange hierarchy of plasma proteins on surfaces [35].
Protein Blood plasma
concentration (mg/ml)
Molecular weight
(Da)
Albumin 40 66,000
Immunoglobulin-G 15 150,000
Fibrinogen 3 340,000
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Factor XII 0,015–0,047 80,000
ace of materials. More speciﬁcally, when a surface is exposed
o blood plasma, certain molecules are preferentially deposited
rom the bulk and both the afﬁnity of proteins for the surface (e.g.
ize, charge, conformational stability) and kinetic factors (e.g. size,
oncentration) contribute to determine the proﬁle of molecules
tably adsorbed on the surface. Simply considering the diffusion,
olecules that are present in the bulk solution at high concen-
ration and/or with small size are deposited quicker than low
oncentrated and/or heavier ones (Table 2).
The strength of the adhesion on the biomaterial plays also a
ole. Indeed, molecules presenting greater afﬁnity for the surface
ay  induce the detaching of the previously and less afﬁne adsorbed
nes. These exchanges start to occur when all the binding sites
f the substrate are occupied and continue until the surface is
opulated with proteins and molecules having strong afﬁnity and
nteraction for the material. This hierarchical tendency has been
alled the Vroman effect [36]. It is thus evident that to avoid com-
etitive protein exchange on surfaces, desired proteins, i.e. FBN,
ould be preferentially immobilized, in order to trigger speciﬁc
esponses. Table 3 summarized the methods that have been pro-
osed to enrich biomaterials interface with FBN highlighting their
ajor issues and anticipates the discussion on the next two  para-
raphs.
.1. Immobilization of heterologous or recombinant ﬁbronectin
The ex vivo decoration of biomaterials with FBN or with its
erived fragment or domains has been for years the gold standard
trategy to enrich scaffolds with cues to direct control cell response.
The immobilization of FBN on scaffold surface may  occur by
hysical adsorption or by surface functionalization and consequent
ovalent immobilization [4]. Even though covalently immobilized
BN is more complex to obtain, it faces and bypasses several
ssues connected to the physical adsorption, i.e. FBN spontaneous
esorption or undesired conformational changes, which in turn
ead to FBN loss of function [37,38]. For instance, in a work by
ustodio et al. the biological activity of FBN simply adsorbed on chi-
able 3
ethods to enrich biomaterial interface with ﬁbronectin.
Fibronectin source Way  to enrich biomaterial interface with ﬁbr
Heterologous
Direct immobilization through physical
adsorption
Surface functionalization and consequent
covalent immobilization
Recombinant
fragments
Direct immobilization through physical
adsorption
Surface functionalization and consequent
covalent immobilization
Recombinant cell binding domains Surface functionalization and consequent co
Autologous
Monoclonal antibody immobilization
Aptamer immobilization nce Review 56 (2020) 50–55 53
tosan or covalently immobilized via carbodiimide chemistry was
compared employing human osteosarcoma SaOs-2 cells [21]. In
opposition to bare chitosan, chitosan with adsorbed or immobilized
FBN promoted cell adhesion. In the presence of FBN cells were well
spread and presented the typical elongated morphology of mature
osteoblasts. No differences were detected among the two methods
in guiding cell adhesion and spreading, indicating that they were
very similar in ameliorating chitosan adhesive properties. On the
other hand, proliferation on FBN-immobilized surfaces was clearly
enhanced after 7 days if compared to FBN-adsorbed chitosan and
to control, suggesting a competitive adsorption of serum proteins
contained in the culturing medium. Accordingly, desorption stud-
ies revealed that surfaces with immobilized FBN retained more
proteins if compared to that with adsorbed FBN. Eventually, this
study highlighted the importance of the covalent immobilization
as a more desirable method to retain bioactive moieties at scaffold
interface.
A clearly limitation linked to the immobilization of entire
FBN is the difﬁculty in completely controlling protein confor-
mational adsorption, which strongly depends on the underlying
substrate. For example, Keselowsky et al. have demonstrated that
the enrichment of a surface with different functionalities dramati-
cally modulated FBN conformational adsorption and cell response,
because of a shift in cell-binding domain availability during FBN
adsorption [39]. As such, the immobilization of FBN recombinant
fragment or of binding domains, have represented a sought after
alternative in the upcoming years. However, since the interaction
of numerous FBN speciﬁc domains (i.e. PHSRN, IKVAV and RGD) is
required for the correct interaction with cell integrins, the anchor-
age of FBN fragment is more desirable than the immobilization of
single binding domains [26,40–42].
3.2. Selective ﬁbronectin binding biomaterials
The enrichment of biomaterials with FBN or with its fragments
is mainly limited by the large molecular weight of FBN, which limits
its stability and bioavailability. Therefore, the creation of selective
ﬁbronectin binding materials is desirable. In this sense, an innova-
tive idea could be the introduction of smaller molecules on scaffold
surface, which could be exploited to capture FBN from the extracel-
lular space and to retain it on the surface [43–45]. The advantages
of this approach appear evident.
The concept of adding selective binding capabilities to bioma-
terials was  ﬁrst considered to promote the retention of the bone
morphogenetic protein 2 (BMP-2) by grafting monoclonal antibod-
ies (mABs) on scaffolds for bone regeneration [46,47]. A similar
approach was  later attempted by Oliveira et al. [48]. However, the
onectin Drawbacks
Possible host immune response;
Possible spontaneous desorption;
Possible adsorption in an undesired conformation.
Possible host immune response;
Possible adsorption in an undesired conformation;
Possible lost of protein mobility.
Possible spontaneous desorption;
Lack of entire protein availability;
High costs of production.
Lack of entire protein availability;
High costs of production.
valent immobilization Lack of speciﬁc binding sites interaction.
Possible host immune response;
High molecular size;
High costs of production.
High costs of production.
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se of mABs is of course limited by compatibility issues, but also
y high costs of production, high size and unability to recognize
mall molecules. As such, to bypass this problem aptamer may
e a viable alternative. Hoffmann et al. were the ﬁrsts to pioneer
his concept in 2011 by using aptamers to retain endothelial cells
rom blood on vascular grafts [49]. Similarly, Chen et al. decorated
ynthetic biomaterials with aptamers to promote the coloniza-
ion by cells, demonstrating an aptamer dose-dependent response
f cell behavior [50]. Both these studies showed the potential of
ptamers in designing selective binding biomaterials. Considering
hese premises, our group has recently demonstrated the possi-
ility to promote the adsorption of serum FBN and to ameliorate
steoblasts colonization by using anti-FBN aptamers to mate-
ials thought for bone and periodontal regeneration [27,31,51].
e tested the aptamer modiﬁcation on two different scaffolds: a
yaluronic acid-based hydrogel (HA) and chitosan-based ﬁlm (CH).
nterestingly, aptamers were able to increase the number of adher-
ng cells in both the cases, which further correlated with the amount
f aptamers used for the functionalization. Remarkable, although
oth aptamer-enriched scaffold showed comparable results in
erm of biological response, protein adsorption and conforma-
ional assays suggested the involvement of different mechanisms.
he aptamer-modiﬁed HA hydrogel increased quantitatively the
mount of adsorbed FBN, enhancing the availability of adhesive
roteins for cells [27]. Conversely, aptamer-enriched CH showed a
imilar amount of adsorbed FBN if compared to its bare counter-
art, but its conformation and function were fully preserved only
n the presence of aptamers [31,51,52].
. Conclusions
Protein adsorption on biomaterials plays a pivotal role in the
ubsequent host reactions, implant integration and tissue regener-
tion. Therefore, its control is a major goal of advanced biomaterial
urfaces. Additionally, the role played by FBN in this arena makes
t the optimal candidate for the amelioration of materials surface
ioactivity. In this work, we focused on the description of this pro-
ein and on its biological role. Furthermore, we gave an overview
n research efforts to ameliorate its adsorption at the interface of
iomaterials. Different methods have been proposed to this pur-
ose and sFBN-materials seemed to be one of the most promising
ystems because of the possibility to maximize the available host
BN retaining all of its bioactivity.
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